Pravin Sudhakar Shirude,Vishweshwaraiah Baligar,Balaji Seshadri,Amit Kumar Chattopadhyay,Nicholas R. Wurtz,Ellen K. Kick
申请号：
US16858319
公开号：
US20200255375A1
申请日:
2020.04.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The disclosure relates to compounds of Formulae (I)-(IX), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
